Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

作者: Melanie Föcking , Patrick Dicker , Jane A. English , K. Oliver Schubert , Michael J. Dunn

DOI: 10.1001/ARCHGENPSYCHIATRY.2011.43

关键词:

摘要: Context: The hippocampus is strongly implicated in schizophrenia and, to a lesser degree, bipolar disorder. Proteomic investigations of the different regions may help us clarify basis and disease specificity changes. Objective: To determine whether disorder are associated with distinct patterns differential protein expression specific hippocampus. Design, Setting, Patients: A postmortem comparative proteomic study, including validation expression, was performed. Midhippocampus samples from well-matched groups 20 subjects schizophrenia, disorder, control cases Stanley Medical Research Institute Array Collection were analyzed. Main Outcome Measures: We used laser-assisted microdissection enrich for tissue hippocampal 2-dimensional difference gel electrophoresis compare profiles. Levels differentially expressed proteins confirmed by enzyme-linked immunosorbent assay Western blotting. Hippocampi haloperidol-treated mice discriminate drug-associated disease-associated Results: Across all regions, 108 spots 165 compared controls. Sixty-one both disorders. One hundred fifty-two these identified mass spectrometry, they range processes cytoskeletal metabolic functions. In disorders, cornu ammonis 2 3 affected significantly greater degree than other regions. Additionally, numerous showed changes more 1 region Validation work septin 11 involved clathrin-mediated endocytosis Conclusions: Overall, similar observed first time indicate that most prominent occur within 3. cellular trafficking process our study. Arch Gen Psychiatry. 2011;68(5):477-488

参考文章(129)
C. Rodemer, V. Haucke, Clathrin/AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? Handbook of experimental pharmacology. ,vol. 186, pp. 105- 122 ,(2008) , 10.1007/978-3-540-72843-6_5
Carri-Lyn R. Mead, Michael A. Kuzyk, Annie Moradian, Gary M. Wilson, Robert A. Holt, Gregg B. Morin, Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin. Journal of Neurochemistry. ,vol. 113, pp. 1491- 1503 ,(2010) , 10.1111/J.1471-4159.2010.06690.X
Britta Qualmann, Michael M. Kessels, Endocytosis and the cytoskeleton. International Review of Cytology-a Survey of Cell Biology. ,vol. 220, pp. 93- 144 ,(2002) , 10.1016/S0074-7696(02)20004-2
Amanda J. Law, Cynthia Shannon Weickert, Thomas M. Hyde, Joel E. Kleinman, Paul J. Harrison, Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines American Journal of Psychiatry. ,vol. 161, pp. 1848- 1855 ,(2004) , 10.1176/AJP.161.10.1848
Melanie Föcking, Paul J. Boersema, Niaobh O'Donoghue, Gert Lubec, Stephen R. Pennington, David R. Cotter, Michael J. Dunn, 2-D DIGE as a quantitative tool for investigating the HUPO Brain Proteome Project mouse series. Proteomics. ,vol. 6, pp. 4914- 4931 ,(2006) , 10.1002/PMIC.200600269
Christine Konradi, Molly Eaton, Matthew L. MacDonald, John Walsh, Francine M. Benes, Stephan Heckers, Molecular evidence for mitochondrial dysfunction in bipolar disorder. Archives of General Psychiatry. ,vol. 61, pp. 300- 308 ,(2004) , 10.1001/ARCHPSYC.61.3.300
M B Knable, B M Barci, M J Webster, J Meador-Woodruff, E F Torrey, Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium Molecular Psychiatry. ,vol. 9, pp. 609- 620 ,(2004) , 10.1038/SJ.MP.4001471
Francine M Benes, Sabina Berretta, GABAergic Interneurons Implications for Understanding Schizophrenia and Bipolar Disorder Neuropsychopharmacology. ,vol. 25, pp. 1- 27 ,(2001) , 10.1016/S0893-133X(01)00225-1